Studies involving the evaluation of the sensitivity to different anticancer agents and MRP4 expression levels will shed some light upon MRP4 role in PDAC chemoresistance and could possibly identify promising therapeutic combinations for cancer treatment. Here, ABCC4 is linked to cancer.